PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.17%
Revenue growth above 1.5x AVGO's 6.34%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
14.83%
Gross profit growth above 1.5x AVGO's 9.30%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
20.69%
Positive EBIT growth while AVGO is negative. John Neff might see a substantial edge in operational management.
20.69%
Positive operating income growth while AVGO is negative. John Neff might view this as a competitive edge in operations.
11.27%
Positive net income growth while AVGO is negative. John Neff might see a big relative performance advantage.
10.87%
Positive EPS growth while AVGO is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
11.11%
Positive diluted EPS growth while AVGO is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
-0.16%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
6.41%
Positive OCF growth while AVGO is negative. John Neff would see this as a clear operational advantage vs. the competitor.
40.87%
Positive FCF growth while AVGO is negative. John Neff would see a strong competitive edge in net cash generation.
154.96%
10Y revenue/share CAGR under 50% of AVGO's 739.51%. Michael Burry would suspect a lasting competitive disadvantage.
241.93%
5Y revenue/share CAGR at 50-75% of AVGO's 407.01%. Martin Whitman would worry about a lagging mid-term growth trajectory.
152.42%
3Y revenue/share CAGR 1.25-1.5x AVGO's 125.80%. Bruce Berkowitz might see better product or regional expansions than the competitor.
812.25%
10Y OCF/share CAGR under 50% of AVGO's 28544.39%. Michael Burry would worry about a persistent underperformance in cash creation.
737.42%
5Y OCF/share CAGR above 1.5x AVGO's 478.10%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
432.15%
3Y OCF/share CAGR above 1.5x AVGO's 210.70%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
545.17%
Below 50% of AVGO's 4089.28%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
1525.76%
5Y net income/share CAGR above 1.5x AVGO's 118.26%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
741.04%
Positive short-term CAGR while AVGO is negative. John Neff would see a clear advantage in near-term profit trajectory.
158.52%
Equity/share CAGR of 158.52% while AVGO is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
62.83%
Below 50% of AVGO's 381.98%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
53.45%
Below 50% of AVGO's 213.27%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
100.21%
Below 50% of AVGO's 968.63%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
79.22%
Below 50% of AVGO's 504.14%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
-3.56%
Firm’s AR is declining while AVGO shows 10.59%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
0.13%
We show growth while AVGO is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
1.95%
Asset growth well under 50% of AVGO's 43.86%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
3.29%
Positive BV/share change while AVGO is negative. John Neff sees a clear edge over a competitor losing equity.
No Data
No Data available this quarter, please select a different quarter.
6.69%
R&D dropping or stable vs. AVGO's 19.51%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
5.00%
SG&A declining or stable vs. AVGO's 98.73%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.